Old Web
English
Sign In
Acemap
>
authorDetail
>
Sebastian Zimmermann
Sebastian Zimmermann
University of Würzburg
Medicine
Cabozantinib
Internal medicine
Adverse effect
Protein precipitation
4
Papers
21
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Ruxolitinib exposure in patients with acute and chronic graft versus host disease in routine clinical practice-a prospective single-center trial.
2021
Cancer Chemotherapy and Pharmacology
Nora Isberner
Sabrina Kraus
Götz Ulrich Grigoleit
Fatemeh Aghai
Max Kurlbaum
Sebastian Zimmermann
Hartwig Klinker
Oliver Scherf-Clavel
Show All
Source
Cite
Save
Citations (1)
Simulation-based interpretation of therapeutically monitored cabozantinib plasma concentration in advanced adrenocortical carcinoma with hemodialysis.
2021
Therapeutic Drug Monitoring
Sebastian Zimmermann
Max Kurlbaum
Stefanie Mayer
Martin Fassnacht
Matthias Kroiss
Oliver Scherf-Clavel
Show All
Source
Cite
Save
Citations (0)
Development and validation of a sensitive liquid chromatography tandem mass spectrometry assay for the simultaneous determination of ten kinase inhibitors in human serum and plasma.
2020
Analytical and Bioanalytical Chemistry
Fatemeh Aghai
Sebastian Zimmermann
Max Kurlbaum
Pius Jung
Theo Pelzer
Hartwig Klinker
Nora Isberner
Oliver Scherf-Clavel
Show All
Source
Cite
Save
Citations (5)
Objective Response and Prolonged Disease Control of Advanced Adrenocortical Carcinoma With Cabozantinib
2020
The Journal of Clinical Endocrinology and Metabolism
Matthias Kroiss
Felix Megerle
Max Kurlbaum
Sebastian Zimmermann
Julia Wendler
Camilo Jimenez
Constantin Lapa
Marcus Quinkler
Oliver Scherf-Clavel
Mouhammed Amir Habra
Martin Fassnacht
Show All
Source
Cite
Save
Citations (15)
1